|1.||Sadahiro, Sotaro: 10 articles (12/2015 - 03/2004)|
|2.||Suzuki, Toshiyuki: 8 articles (06/2014 - 03/2004)|
|3.||Kamijo, Akemi: 6 articles (06/2014 - 03/2004)|
|4.||Ichinose, Yukito: 6 articles (06/2008 - 12/2003)|
|5.||Fukushima, Masakazu: 6 articles (07/2007 - 07/2005)|
|6.||Ikeda, Masataka: 5 articles (12/2015 - 01/2006)|
|7.||Jakobsen, Anders: 5 articles (08/2015 - 01/2008)|
|8.||Lindebjerg, Jan: 5 articles (08/2015 - 01/2008)|
|9.||Fox, Barbara A: 5 articles (05/2015 - 02/2002)|
|10.||Bzik, David J: 5 articles (05/2015 - 02/2002)|
|1.||Colorectal Neoplasms (Colorectal Cancer)
07/01/2015 - "500 mg/m(2) uracil was administered orally to 12 subjects with stages II-III colorectal cancer (CRC) who were treated in the adjuvant setting and to 12 subjects with stage IV metastasized CRC, all treated with CAP containing therapy. "
07/01/2015 - "Influence of metastatic disease on the usefulness of uracil pharmacokinetics as a screening tool for DPD activity in colorectal cancer patients."
06/01/1996 - "fluoropyrimidine, in comparison to 1 M tegafur-4 M uracil [(UFT) effective on colorectal tumor in clinical]. "
04/01/2008 - "We report two cases of recurrent colorectal cancer in two patients who were treated successfully with a combined oral chemotherapeutic agent folinate/tegafur/uracil (UFT/LV) dosage. "
01/01/2007 - "This study was conducted to examine changes in DPD activity in peripheral mononuclear cells (PMNC) during long-term treatment with oral uracil and tegafur (UFT) for colorectal cancer. "
09/01/2013 - "We speculate that a better understanding of host-parasite interaction at the molecular level and applying improved genetic models based on Δku80 Toxoplasma strains will stimulate development of highly effective immunotherapeutic cancer vaccine strategies using engineered uracil auxotrophs. "
11/01/1997 - "UFT, an oral fluoropyrimidine combined with uracil, is expected to be more effective in such tumors."
09/01/2013 - "Interpreting these findings in the light of previous genetic, cellular and biochemical studies, the most parsimonious conclusion from these global analyses is that APOBEC3B-catalyzed genomic uracil lesions are responsible for a large proportion of both dispersed and clustered mutations in multiple distinct cancers. "
09/01/2006 - "This observation prompted us to examine the data generated from healthy (cancer-free) Indian subjects who were enrolled in a large population study to determine the sensitivity and specificity of the uracil breath test (UraBT) in the detection of DPD deficiency. "
11/25/1983 - "For these studies, we utilized a gas chromatograph-mass spectrometric technique which enabled measurement of 13C incorporation from 13CO2 into the uracil nucleotide pool (sigma uracil) of tumors in situ. "
|3.||Hepatocellular Carcinoma (Hepatoma)
01/01/2008 - "A phase II study of tegafur plus uracil or tegafur alone for the treatment of advanced hepatocellular carcinoma."
10/01/2006 - "Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial."
05/01/1990 - "In a randomized trial, Tegafur (FT-207) or Tegafur-Uracil (UFT) was administrated to 76 patients with advanced hepatocellular carcinoma for whom transcatheter arterial embolization could not be applied. "
07/01/2013 - "Oral tegafur/uracil therapy has been indicated for patients with hepatocellular carcinoma (HCC) and is often used as a single-agent treatment. "
01/01/2007 - "We encountered a case of peritoneal dissemination of hepatocellular carcinoma, successfully treated with a combination therapy of interferon-alpha-2b and oral tegafur/uracil. "
|4.||Neoplasm Metastasis (Metastasis)
07/01/2015 - "Metastasis does not alter uracil pharmacokinetics and is similar in CRC patients with and without metastasis. "
01/01/1968 - "[Study of doubling time variations in pulmonary metastases of rectocolonic cancers treated by fluoro-5-uracil]."
07/01/2015 - "Following administration of chemoradiation therapy with tegafur-uracil and 45 Gy due to local recurrence at postoperative 13 months, there was no local recurrence or distant metastases. "
06/01/2015 - "Considering resectable metastasis, 6 courses of FOLFOX (5 fluoro-uracil + oxaliplatin) will be administered before and after surgery in the goal of "cleaning" the body from the potential micrometastasis. "
06/01/2014 - "The tegafur-uracil treatment resulted in the disappearance of pulmonary metastases, and a stabilization of the bone metastases. "
11/01/1984 - "The differential tissue uptake and blood clearance of [2-14C]-5-ethyl-1-(2'-deoxy-beta-D-ribofuranosyl)uracil [2-14C]-5-EtUdR) in BDF1 mice bearing Lewis Lung carcinomas has been investigated. "
07/01/1999 - "Group 1: females treated with 3% uracil (100% carcinoma incidence). "
10/01/1995 - "These findings indicate strain and possibly sex differences in kidney carcinogenesis in rats treated with EHEN and uracil, and simultaneous administration of the two agents to male Wistar rats might have an advantage for models to induce advanced renal carcinoma at a high incidence."
05/01/1992 - "5 fluoro-uracil (5 FU) is a compound widely used in the treatment of ENT, breast and gastrointestinal carcinomas. "
03/01/1998 - "Adjuvant chemotherapy with oral tegaful and uracil for maxillary sinus carcinoma."
|2.||Leucovorin (Folinic Acid)
|8.||Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)
|1.||Drug Therapy (Chemotherapy)
|4.||Combination Drug Therapy (Combination Chemotherapy)